Altimmune, Inc. (NASDAQ:ALT) filed a Form 8-K with the Securities and Exchange Commission on January 28, 2026, disclosing a material event.
Altimmune, Inc.'s stock currently trades at $5.12 with a market capitalization of $471.3M. The Healthcare company's stock moved following the disclosure.